CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY - A CLINICOPATHOLOGICAL STUDY OF 96 PATIENTS

被引:105
|
作者
DEMETRIS, AJ
FUNG, JJ
TODO, S
MCCAULEY, J
JAIN, A
TAKAYA, S
ALESSIANI, M
ABUELMAGD, K
VANTHIEL, DH
STARZL, TE
机构
[1] UNIV PITTSBURGH,PRESBYTERIAN UNIV HOSP,DEPT TRANSPLANTAT SURG,PITTSBURGH,PA 15213
[2] UNIV PITTSBURGH,PRESBYTERIAN UNIV HOSP,DEPT MED,PITTSBURGH,PA 15213
关键词
D O I
10.1097/00007890-199205000-00017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of conversion from cyclosporine-steroid immunosuppression to the new agent FK506 was studied in 96 liver allograft recipients who were experiencing graft dysfunction or cyclosporine toxicity. Patients were stratified according to the cause of graft dysfunction that ultimately led to conversion to FK506. Response to FK506 introduction was monitored pathologically and biochemically. The outcome of a switch from CsA to FK506 was highly favorable in patients experiencing acute and the early stages of chronic rejection, despite optimal conventional therapy. Patients with later stages of chronic rejection did not respond to conversion to FK506 and most eventually lost their liver grafts in this process. Patients in whom we had difficulty separating chronic rejection from chronic persistent or low-grade chronic active hepatitis were mostly unaffected by conversion to FK506. Active hepatitis was a poor indication for conversion, because most of the patients experienced graft failure or died from liver failure. As a group, there was no statistically significant change in renal function 180 days after conversion to FK506. These findings expand the experience with FK506 in human liver allograft recipients.
引用
收藏
页码:1056 / 1062
页数:7
相关论文
共 50 条
  • [1] Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy
    Ben-Ari, Z
    Mor, E
    Shaharabani, E
    Bar-Nathan, N
    Shapira, Z
    Tur-Kaspa, R
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (04) : 709 - 710
  • [2] FK506 HEPATOTOXICITY IN LIVER ALLOGRAFT RECIPIENTS
    FISHER, A
    MOR, E
    HYTIROGLOU, P
    EMRE, S
    BOCCAGNI, P
    CHODOFF, L
    SHEINER, P
    SCHWARTZ, M
    THUNG, SN
    MILLER, C
    [J]. TRANSPLANTATION, 1995, 59 (11) : 1631 - 1632
  • [3] FK506 VERSUS CYCLOSPORINE AS PRIMARY IMMUNOSUPPRESSIVE AGENT FOR ORTHOTOPIC LIVER ALLOGRAFT RECIPIENTS - HISTOLOGIC AND IMMUNOPATHOLOGIC OBSERVATIONS
    HYTIROGLOU, P
    LEE, R
    SHARMA, K
    THEISE, ND
    SCHWARTZ, M
    MILLER, C
    THUNG, SN
    [J]. TRANSPLANTATION, 1993, 56 (06) : 1389 - 1394
  • [4] CONVERSION FROM CYCLOSPORINE TO FK-506 IN LIVER ALLOGRAFT RECIPIENTS WITH CYCLOSPORINE-RELATED COMPLICATIONS
    FUNG, JJ
    TODO, S
    JAIN, A
    MCCAULEY, J
    ALESSIANI, M
    SCOTTI, C
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 6 - 12
  • [5] LONG-TERM EFFECTS OF FK506 FOLLOWING CONVERSION FROM CYCLOSPORINE TO FK506 FOR CHRONIC REJECTION IN LIVER-TRANSPLANT RECIPIENTS
    FUNG, JJ
    JAIN, A
    HAMMAD, I
    DOYLE, H
    SELBY, R
    TZAKIS, AG
    TODO, S
    STARZL, TE
    [J]. HEPATOLOGY, 1993, 18 (04) : A74 - A74
  • [6] COMPARISON OF THE IMMUNOSUPPRESSIVE AND TOXIC EFFECTS OF FK506 AND CYCLOSPORINE IN XENOGRAFT RECIPIENTS
    GUDAS, VM
    CARMICHAEL, PG
    MORRIS, RE
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1072 - 1073
  • [7] FK506 CONVERSION FOR INTRACTABLE REJECTION OF THE LIVER ALLOGRAFT
    MCDIARMID, SV
    KLINTMALM, GB
    BUSUTTIL, RW
    [J]. TRANSPLANT INTERNATIONAL, 1993, 6 (06) : 305 - 312
  • [8] CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK 506-BASED IMMUNOSUPPRESSION - BENEFITS AND PITFALLS
    FUNG, JJ
    TODO, S
    TZAKIS, A
    DEMETRIS, A
    JAIN, A
    ABUELMAGD, K
    ALESSIANI, M
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 14 - 21
  • [9] Renal allograft rejection in patients receiving FK506 as primary immunosuppressive therapy.
    Preston, R
    Ball, S
    Cairns, T
    Contis, J
    Hakim, N
    Palmer, A
    Papalois, V
    Taube, D
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2592 - 2592
  • [10] RENAL-FUNCTION IN LIVER-TRANSPLANT PATIENTS RECEIVING FK506 OR CYCLOSPORINE-A IMMUNOSUPPRESSIVE THERAPY
    FREI, U
    WAGNER, K
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3270 - 3271